Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-01-10, Stock:LLY, The news for the past five days is as follows:
2019-01-03: NEWS1: Lilly to Participate in J.P. Morgan Healthcare Conference.NEWS2: Bristol-Myers Angles To Become Mega-Pharma With $74 Billion Celgene Bid.NEWS3: iShares Edge MSCI USA Momentum Factor ETF Experiences Big Outflow.NEWS4: iShares Edge MSCI USA Momentum Factor ETF Experiences Big Outflow.NEWS5: The Zacks Analyst Blog Highlights: TripAdvisor, Advance Auto, Red Hat, Salesforce and Eli Lily.NEWS6: The Zacks Analyst Blog Highlights: TripAdvisor, Advance Auto, Red Hat, Salesforce and Eli Lily.NEWS7: The Zacks Analyst Blog Highlights: TripAdvisor, Advance Auto, Red Hat, Salesforce and Eli Lily.
2019-01-04: NEWS1: Pharma Stock Roundup: BMY to Buy CELG for $74B, MRK Gets Rights to NASH Candidate.NEWS2: Pharma Stock Roundup: BMY to Buy CELG for $74B, MRK Gets Rights to NASH Candidate.NEWS3: Nektar, ImaginAb Enter Into Immuno-Oncology Collaboration.NEWS4: Nektar, ImaginAb Enter Into Immuno-Oncology Collaboration.NEWS5: Pharma Stock Roundup: BMY to Buy CELG for $74B, MRK Gets Rights to NASH Candidate.NEWS6: Selecta Biosciences Eliminates 36% Of Workforce.NEWS7: Selecta Biosciences Eliminates 36% Of Workforce.
2019-01-07: NEWS1: Biotech Stocks Post Double-Digit Gains in Monday Surge.NEWS2: What Happened in the Stock Market Today.NEWS3: What Happened in the Stock Market Today.NEWS4: Here's Why DexCom Traded 11.8% Higher Today.NEWS5: Here's Why DexCom Traded 11.8% Higher Today.NEWS6: LOXO, LLY: Loxo Oncology Stock Soars on $8 Billion Eli Lilly Deal.NEWS7: LOXO, LLY: Loxo Oncology Stock Soars on $8 Billion Eli Lilly Deal.NEWS8: Lilly makes $8 billion bet on drugs for rare cancers with Loxo Oncology buy.NEWS9: Lilly makes $8 billion bet on drugs for rare cancers with Loxo Oncology buy.NEWS10: Eli Lilly (LLY) Gains But Lags Market: What You Should Know.NEWS11: Why Array BioPharma, Deciphera Pharmaceuticals, and Blueprint Medicines Are Up by Double Digits Today.NEWS12: Why Array BioPharma, Deciphera Pharmaceuticals, and Blueprint Medicines Are Up by Double Digits Today.NEWS13: Biogen Inks Two Deals to Make Drugs for Neurological Diseases.NEWS14: Biogen Inks Two Deals to Make Drugs for Neurological Diseases.NEWS15: Here's what Amgen's CEO said about the future of the heal....NEWS16: ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Loxo Oncology, Inc..NEWS17: Mid-Afternoon Market Update: Dow Up 125 Points; Axsome Therapeutics Shares Spike Higher.NEWS18: Mid-Afternoon Market Update: Dow Up 125 Points; Axsome Therapeutics Shares Spike Higher.NEWS19: 3 Things to Know at Market Close: Tesla Grows In China, Pharma Binds, GE Unwinds.NEWS20: What Happened in the Stock Market Today.NEWS21: Biotech's big conference living up to reputation with big deals, big costs.NEWS22: Stocks climb on trade talks and encouraging economic report.NEWS23: Noteworthy Monday Option Activity: LLY, CENT, MS.NEWS24: Noteworthy Monday Option Activity: LLY, CENT, MS.NEWS25: Close Update: Wall Street Adds to Gains as US-China Trade Talks Boost Sentiment.NEWS26: Close Update: Wall Street Adds to Gains as US-China Trade Talks Boost Sentiment.NEWS27: Loxo Oncology, Dollar Tree and Schlumberger rise; PG&E sinks.NEWS28: Jim Cramer: Innovation Is on Display at the J.P. Morgan Healthcare Conference.NEWS29: Dow Pares Gains Into Close as Wall Street Monitors U.S.-China Trade Talks.NEWS30: Biogen Inks Two Deals to Make Drugs for Neurological Diseases.NEWS31: Why Array BioPharma, Deciphera Pharmaceuticals, and Blueprint Medicines Are Up by Double Digits Today.NEWS32: Mid-Day Market Update: Luxoft Jumps On Acquisition News; PG&E Shares Tumble.NEWS33: Mid-Day Market Update: Luxoft Jumps On Acquisition News; PG&E Shares Tumble.NEWS34: AXSM Awes Investors, LOXO Snapped Up For $8 Bln, SAGE Excited, TLC On Watch.NEWS35: AXSM Awes Investors, LOXO Snapped Up For $8 Bln, SAGE Excited, TLC On Watch.NEWS36: Celgene Expects to Generate Up to $17.2 Billion in Revenue in 2019.NEWS37: Cancer stocks heat up after third big merger in the past month.NEWS38: SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Loxo Oncology, Inc. to Eli Lilly and Company is Fair to Shareholders.NEWS39: Three Healthcare Stocks Rallying Over 10% Today.NEWS40: Dow Rises as Wall Street Monitors U.S.-China Trade Talks.NEWS41: Pfizer or Eli Lilly: Whose Revenue Is Growing More Quickly?.NEWS42: Why Agenus Stock Is Spiking Today.NEWS43: Why Agenus Stock Is Spiking Today.NEWS44: Biotech ETFs Surge After Eli Lilly Buys Out Loxo Oncology.NEWS45: Lilly to buy Loxo Oncology for $8 bln.NEWS46: US stocks climb, led by retailers and smaller companies.NEWS47: Eli Lilly and Company -- Moody's affirms Eli Lilly's A2/P-1 ratings; stable outlook.NEWS48: Mid-Day Update: Dow Sets 2-Week High As Trade Talks Resume.NEWS49: Mid-Day Update: Dow Sets 2-Week High As Trade Talks Resume.NEWS50: Analysts’ Recommendations for Eli Lilly in January.NEWS51: Stocks Climb as U.S.-China Trade Talks Begin.NEWS52: Why Agenus Stock Is Spiking Today.NEWS53: Here's Why Loxo Oncology Is Skyrocketing Today.NEWS54: Here's Why Loxo Oncology Is Skyrocketing Today.NEWS55: Mid-Morning Market Update: Markets Mixed; Commercial Metals Misses Q1 Views.NEWS56: Mid-Morning Market Update: Markets Mixed; Commercial Metals Misses Q1 Views.NEWS57: Eli Lilly to Buy Loxo Oncology for $8 Billion in Second Major 2019 Drug Takeover.NEWS58: Optimism About Trade Talks Leads To Strength On Wall Street - U.S. Commentary.NEWS59: Optimism About Trade Talks Leads To Strength On Wall Street - U.S. Commentary.NEWS60: Wall Street Cheers Lilly&apos;s $8 Billion Loxo Deal for Cancer Drugs.NEWS61: Here&apos;s Why Loxo Oncology Is Skyrocketing Today.NEWS62: Dow Moves Higher as Wall Street Monitors U.S.-China Trade Talks.NEWS63: US stocks edge higher after huge swings in recent trading.NEWS64: Eli Lilly CEO: Loxo acquisition can help us treat cancer ....NEWS65: Dow Wavers as Wall Street Monitors U.S.-China Trade Talks.NEWS66: Bigfoot Biomedical Announces Next Step for Connected Insulin Injection System.NEWS67: Big Pharma Isn&apos;t Boring Any More as Cancer Deals Herald More M&A.NEWS68: Eli Lilly to Buy Loxo Oncology for $8 Billion.NEWS69: Loxo Oncology Holding On To Substantial Gain In Afternoon Trading.NEWS70: Loxo Oncology Holding On To Substantial Gain In Afternoon Trading.NEWS71: U.S. stocks struggle for direction in early trade, following powerful Friday rally.NEWS72: Eli Lilly Is Buying Loxo Oncology — and Paying a Big Premium for It.NEWS73: US STOCKS-Futures flat after Wall Street's strongest surge in 2019.NEWS74: Eli Lilly confirms $8 billion takeover of Loxo Oncology.NEWS75: Why Loxo Oncology Has Surged More than 65% Today.NEWS76: Stocks making the biggest moves premarket: LLY, AAPL, TSLA, AMZN & more.NEWS77: Opportunities for investors in health care sector?.NEWS78: Eli Lilly to spend about $8B on Loxo Oncology.NEWS79: [$$] Eli Lilly to buy Loxo Oncology for $8bn in cancer drug push.NEWS80: Stocks Climbing To New Highs For The Session - U.S. Commentary.NEWS81: Stocks Climbing To New Highs For The Session - U.S. Commentary.NEWS82: Eli Lilly to buy cancer treatment company Loxo Oncology for $8 billion in cash.NEWS83: Lilly to buy Loxo Oncology in a $8 billion deal, for a 68% premium.NEWS84: Stocks Move Mostly Higher On Optimism About Trade Talks - U.S. Commentary.NEWS85: Stocks Move Mostly Higher On Optimism About Trade Talks - U.S. Commentary.NEWS86: Loxo Oncology Inc. (LOXO) Has Broken Out To A New High After Bought By Lilly.NEWS87: Loxo Oncology Inc. (LOXO) Has Broken Out To A New High After Bought By Lilly.NEWS88: Stocks - Wall Street Struggles for Direction at Start of the Week.NEWS89: Stocks May Show A Lack Of Direction In Early Trading - U.S. Commentary.NEWS90: Stocks May Show A Lack Of Direction In Early Trading - U.S. Commentary.NEWS91: Lilly To Buy Loxo Oncology In $8.0 Bln Deal.NEWS92: Lilly To Buy Loxo Oncology In $8.0 Bln Deal.
2019-01-08: NEWS1: Eli Lilly giving price info on advertised drugs via website.NEWS2: Eli Lilly giving price info on advertised drugs via website.NEWS3: Why Eli Lilly Is Buying Loxo Oncology for $8 Billion.NEWS4: WEISSLAW LLP: Loxo Oncology, Inc. Acquisition May Not Be In The Best Interests of LOXO Shareholders.NEWS5: Crowded Cancer Space Triggers Big M&A Deals: More in Store?.NEWS6: Crowded Cancer Space Triggers Big M&A Deals: More in Store?.NEWS7: Lilly Offers $8B to Acquire Cancer-Focused Small Biotech Loxo.NEWS8: Lilly Offers $8B to Acquire Cancer-Focused Small Biotech Loxo.NEWS9: Eli Lilly (LLY) is a Great Momentum Stock: Should You Buy?.NEWS10: Eli Lilly (LLY) is a Great Momentum Stock: Should You Buy?.NEWS11: Loxo Oncology Is Expected to Boost Eli Lilly’s Revenue in 2019.NEWS12: Eli Lilly to cut 250 jobs at France plant, through voluntary redundancy.NEWS13: Eli Lilly to cut 250 jobs at France plant, through voluntary redundancy.NEWS14: Company News For Jan 8, 2019.NEWS15: Company News For Jan 8, 2019.NEWS16: Is Eli Lilly Overpaying for Loxo Oncology?.NEWS17: Is Eli Lilly Overpaying for Loxo Oncology?.NEWS18: Pfizer or Eli Lilly: Which Company Is More Cost Efficient?.NEWS19: Eli Lilly (LLY) is a Great Momentum Stock: Should You Buy?.NEWS20: What Are Analysts Recommending for Eli Lilly and Loxo Oncology?.NEWS21: Lilly Offers $8B to Acquire Cancer-Focused Small Biotech Loxo.NEWS22: Crowded Cancer Space Triggers Big M&A Deals: More in Store?.NEWS23: 4 Biotechs That Are Potential Buyouts Post Celgene Deal.NEWS24: 4 Biotechs That Are Potential Buyouts Post Celgene Deal.NEWS25: Company News For Jan 8, 2019.NEWS26: Pfizer or Eli Lilly: Which Company Has Better Margins?.NEWS27: 4 Biotechs That Are Potential Buyouts Post Celgene Deal.NEWS28: Is Eli Lilly Overpaying for Loxo Oncology?.NEWS29: Eli Lilly Is Set to Acquire Loxo Oncology.NEWS30: Two ways to play the biotech boom.NEWS31: Pfizer or Eli Lilly: Whose Earnings Are Seeing Better Growth?.NEWS32: Debt Buybacks Could Be The New Stock Buybacks.NEWS33: Deal-making in the global health-care sector is set to rebound in 2019, law firm says.NEWS34: Asian shares mixed amid silence on China-US trade talks.NEWS35: Asian shares mixed amid silence on China-US trade talks.NEWS36: [$$] Eli Lilly to Buy Loxo Oncology in $8 Billion Deal.NEWS37: Lilly makes $8 billion bet on drugs for rare cancers with Loxo Oncology buy.NEWS38: So Long, Loxo.NEWS39: So Long, Loxo.NEWS40: Gilead, Pfizer Execs Suggest Even More Pharma M&A Is on Way.NEWS41: PRESS DIGEST- Financial Times - Jan 8.NEWS42: [$$] Good News for Biotech: Shoppers Unfazed by Selloff.NEWS43: Eli Lilly (LLY) Gains But Lags Market: What You Should Know.NEWS44: Eli Lilly (LLY) Gains But Lags Market: What You Should Know.NEWS45: 5 Must-See Stock Charts for Tuesday, Including Roku.NEWS46: 5 Must-See Stock Charts for Tuesday, Including Roku.NEWS47: Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Loxo Oncology, Inc. (LOXO) on Behalf of Stockholders and Encourages LOXO Investors to Contact the Firm.NEWS48: Jim Cramer: These Pharma Deals Are Game Changers.
2019-01-09: NEWS1: CNBC'S CHRISTINA FARR & ANGELICA LAVITO: JP MORGAN'S DIMON HOSTED A DINNER FOR PHARMA EXECUTIVES, AND A MAJOR TOPIC WAS AMAZON.NEWS2: JP Morgan's Dimon hosted a dinner for pharma executives, and a major topic was Amazon.NEWS3: MERGER ALERT – BDMS, LOXO and MB: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies.NEWS4: Novartis' Crizanlizumab Gets Breakthrough Therapy Status.NEWS5: Novartis' Crizanlizumab Gets Breakthrough Therapy Status.NEWS6: The Zacks Analyst Blog Highlights: Bristol-Myers, Celgene, Lilly and Glaxo.NEWS7: The Zacks Analyst Blog Highlights: Bristol-Myers, Celgene, Lilly and Glaxo.NEWS8: The Zacks Analyst Blog Highlights: Bristol-Myers, Celgene, Lilly and Glaxo.NEWS9: Novartis' Crizanlizumab Gets Breakthrough Therapy Status.NEWS10: Does Eli Lilly&apos;s $8 Billion Splurge Make Array BioPharma a Buy Now?.NEWS11: See what the IHS Markit Score report has to say about Eli Lilly and Co..NEWS12: Eli Lilly and Loxo: A Robust Oncology Pipeline for Future Years.NEWS13: Pfizer or Eli Lilly: Which Company Has the Better Dividend Policy?.NEWS14: Report: Exploring Fundamental Drivers Behind Virtusa, Eli Lilly, Cree, NewJersey Resources, Getty Realty, and PennantPark Investment — New Horizons, Emerging Trends, and Upcoming Developments.NEWS15: A Pension Fund Bought Apple Stock at the Wrong Time.NEWS16: Why Eli Lilly Is Buying Loxo Oncology for $8 Billion.NEWS17: Why Eli Lilly Is Buying Loxo Oncology for $8 Billion.NEWS18: Would-Be Dealmakers Warn of M&A, IPO Delays Due to Shutdown.

Answer: Decrease